Skip to content

A Comparison of 4% Articaine Versus 0.5%Bupivacaine for Ambulatory Surgery Under Supraclavicular Block

A Randomized Controlled Trial : Comparison of 4% Articaine Versus 0.5% Bupivacaine for Ambulatory Orthopaedic Surgery Under Supraclavicular Block

Status
Completed
Phases
Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04189198
Enrollment
60
Registered
2019-12-06
Start date
2019-12-30
Completion date
2020-03-27
Last updated
2020-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Upper Limb Surgery, Hand Surgery

Keywords

Articaine, Bupivacaine, Ultrasound, Supraclavicular block

Brief summary

Effect of 2%Articaine versus 5%bupivacaine in pt undergoing short duration surgery in upper limb

Detailed description

The investigator aim to compare Articaine 2% versus bupivacaine 0.5% in patient undergoing upper limb procedure under ultrasound guided supraclavicular block as regard onset and duration of sensory and motor block

Interventions

Supraclavicular block with 30 ml articaine 2%

DRUGBupivacaine

Supraclavicular block with 30 ml bupivacaine 0.5%

Sponsors

Ain Shams University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
TRIPLE (Subject, Caregiver, Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
Yes

Inclusion criteria

* upper limb surgery * ganglion removal * k wiring * Carapal tunnel

Exclusion criteria

* Coagulopathy. * infection at site of injection. * patient refusal. * hypersensitivity.

Design outcomes

Primary

MeasureTime frameDescription
Duration of sensory blockMeasured in minutes over 24 hoursBy pinprick test from 0 to 2 where 0 no sensory block and 2 complete anesthesia
Durations of motor blockMeasured in minutes over 24 hoursBy Bromage scale from 1 to 4 where 1 no motor power and 4 full motor power
Duration of analgesiaMeasured in minutes over 24 hoursMeasured by numerical analog scale where 0 no pain and 10 means worst pain

Secondary

MeasureTime frameDescription
Analgesia24 hoursFirst analgesia required

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 17, 2026